In May, we spotlighted Cellceutix as they continue to move towards a potential breakthrough in Autism research. Today, they responded to overwhelming public support regarding this matter in a press release. The company is expediting research and collaborating with the InterEd Faculty of Clinical Research (IFCR) to accelerate the development of KM-391, which as we mentioned in our previous post has potential links to Autism.
Very exciting and interesting news- we are keeping our fingers crossed as this research develops further.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment